设为首页 加入收藏

TOP

TARGRETIN capsules 75mg(タルグレチンカプセル75mg)
2017-02-15 10:20:40 来源: 作者: 【 】 浏览:526次 评论:0

Internal
Published: 1/2017

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
TARGRETIN capsules 75mg
 Active ingredient:
Bexarotene
 Dosage form:
white soft capsules, major axis: approximately 20.6 mm, minor axis: approximately 8.6 mm
 Print on wrapping:
(face)タルグレチンカプセル75mg, (back)タルグレチンカプセル75mg

Effects of this medicine

This medicine binds to retinoid X receptor and suppresses growth of cancer cells (tumors).
It is usually used to treat cutaneous T cell lymphoma.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you have liver disorder or hypervitaminosis A.
    If you have a history of pancreatitis.
    If you have a risk factor of pancreatitis.
  • If you are pregnant, possibly pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • In general, for adults, take this medicine once a day after meals. The dosage will be determined based on body surface area (BSA) as follows: 4 capsules (300 mg of the active ingredient) per dose for patients with 0.88 to 1.12 m2 of BSA, 5 capsules (375 mg) per dose for patients with 1.13 to 1.37 m2 of BSA, 6 capsules (450 mg) per dose for patients with 1.38 to 1.62 m2 of BSA, 7 capsules (525 mg) per dose for patients with 1.63 to 1.87 m2 of BSA, 8 capsules (600 mg) per dose for patients with 1.88 to 2.12 m2 of BSA, 9 capsules (675 mg) per dose for patients with 2.13 to 2.37 m2 of BSA, 10 capsules (750 mg) per dose for patients with 2.38 to 2.62 m2 of BSA. The dosage will be adjusted according to your symptoms. Strictly follow the instructions.
  • If you miss a dose, take the missed dose as soon as possible. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. You should never take two doses at one time.
  • If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
  • Do not stop taking this medicine unless your doctor instructs you to do so.

Precautions while taking this medicine

  • Teratogenic action (possibility to cause fetal malformation) has been reported in animal experiments. If you have a possibility of pregnancy, be sure to avoid pregnancy at least for 1 month before you start this medicine, while you are taking it, and for 1 month after you discontinue it. Since this medicine may diminish the medicinal effect of oral contraceptive agents, avoid using oral contraceptive agents as monotherapy. Use 2 or more birth control methods in combination. Have a pregnancy test periodically in order to confirm that you do not become pregnant.
  • If your partner has a possibility of pregnancy, be sure to avoid pregnancy while you are taking it and for at least 3 month after you discontinue it.
  • Photosensitivity may occur while you are taking this medicine. Avoid exposure to sunlight by wearing hats or clothing, etc., or by using highly effective sunscreens when you are outside.

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include hypothyroidism, anemia, headache, nausea, vomiting, liver dysfunction and malaise. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • high lipid level detected with a blood test [hyperlipidemia (hypertriglyceridemia, hypercholesteremia)]
  • nausea, vomiting, severe gastric/abdominal pain, back pain [pancreatitis]
  • dullness, edema, intolerance to the cold, slowness in motion or in conversation, light headedness, lassitude, cold sweat, dizziness, headache, palpitation, a sense of hunger, shaking limbs [pituitary hypothyroidism, hypoglycemia]
  • fever, sore throat, dullness, dizziness, headache, ear ringing, palpitation, shortness of breath [leukopenia, neutropenia, anemia]
  • nausea, vomiting, loss of appetite, flapping tremor, dullness, yellowing of the whites of eyes, nausea, vomiting, loss of appetite, itch, yellowing of the skin, dark urine [liver failure, liver dysfunction]
  • cold-like symptom, dullness, fever, vomiting [infection]
  • fever, dry cough, breathing difficulty, shortness of breath [interstitial pulmonary disease]
  • vomiting of blood, nausea, vomiting, chest pain, chest tightness, pressure in chest, severe abdominal pain, abdominal bloating, severe pain in legs, bleeding, anesthesia [thromboembolism]
  • lassitude, numbness of hands, stiffness in limbs, numbness of legs, muscle pain, reddish-brown urine [rhabdomyolysis]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • Keep out of the reach of children. Store away from light, heat and moisture.
  •  Discard the remainder. Do not store them. Ask the pharmacist and the medical institution how to discard them.
以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇タルグレチンカプセル(TARGRETIN.. 下一篇アプテシンカプセル150mg(APTECI..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位